An in-depth look to MAXIGEN BIOTECH INC operating, investing, and financing activities

1783 free cash flow for Q3 24 is 111.37 M TWD. For 2023, 1783 free cash flow was 148.71 M TWD and operating cash flow was 171.15 M TWD.